JP2011529904A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529904A5
JP2011529904A5 JP2011521327A JP2011521327A JP2011529904A5 JP 2011529904 A5 JP2011529904 A5 JP 2011529904A5 JP 2011521327 A JP2011521327 A JP 2011521327A JP 2011521327 A JP2011521327 A JP 2011521327A JP 2011529904 A5 JP2011529904 A5 JP 2011529904A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
leu
romidepsin
composition according
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2011521327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529904A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/052269 external-priority patent/WO2010014819A1/en
Publication of JP2011529904A publication Critical patent/JP2011529904A/ja
Publication of JP2011529904A5 publication Critical patent/JP2011529904A5/ja
Abandoned legal-status Critical Current

Links

JP2011521327A 2008-07-30 2009-07-30 加速された療法 Abandoned JP2011529904A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8479708P 2008-07-30 2008-07-30
US61/084,797 2008-07-30
PCT/US2009/052269 WO2010014819A1 (en) 2008-07-30 2009-07-30 Accelerated therapy

Publications (2)

Publication Number Publication Date
JP2011529904A JP2011529904A (ja) 2011-12-15
JP2011529904A5 true JP2011529904A5 (https=) 2012-09-13

Family

ID=41610730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521327A Abandoned JP2011529904A (ja) 2008-07-30 2009-07-30 加速された療法

Country Status (6)

Country Link
US (1) US20100152100A1 (https=)
EP (1) EP2309854A4 (https=)
JP (1) JP2011529904A (https=)
CA (1) CA2732294A1 (https=)
MX (1) MX2011001132A (https=)
WO (1) WO2010014819A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101687010A (zh) * 2006-12-29 2010-03-31 格洛斯特制药公司 制备Romidepsin
AU2007342028B2 (en) 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
BR112013004714A2 (pt) * 2010-09-01 2016-05-17 Novartis Ag "combinações de inibidores de hdac com fármacos de trombocitopenia e seus usos"
US8859502B2 (en) * 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
ES2750308T3 (es) 2015-05-22 2020-03-25 Bioiberica Proceso para preparar un extracto de cerebro de un animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2012801A4 (en) * 2006-04-24 2009-08-05 Gloucester Pharmaceuticals Inc GEMCITABINE COMBINATION THERAPY
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Iii リミテッド 強化剤を含む固体経口投与剤形

Similar Documents

Publication Publication Date Title
JP2010516767A5 (https=)
Markman Managing taxane toxicities
US20220323475A1 (en) Combination therapy for cancer
JP2011529904A5 (https=)
JP2020114837A5 (https=)
US20230149436A1 (en) Combination therapy
JP2017516802A5 (https=)
WO2017109444A1 (en) Combination therapy
EP1905439A1 (en) Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
Hoting et al. Arotinoid‐ethylester. Effectiveness in refractory cutaneous t‐cell lymphoma
US20200197430A1 (en) Combination Therapy
EP4382107A1 (en) Companion drug comprising activity regulator for t cell and/or b cell
AU2005292033A1 (en) Treatment method
JP2022551499A5 (https=)
EP1905437A1 (en) Treatment of pain using satraplatin
RU2325160C1 (ru) Средство для лечения рака предстательной железы и профилактики его рецидива
Kuroi et al. Protracted administration of weekly docetaxel in metastatic breast cancer
RU2162322C1 (ru) Препарат для лечения бронхиальной астмы и способ ее лечения
Bovenschen et al. Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis
JP2024539691A (ja) 重度の注射部位反応を処置及び予防するためのプロセス及び治療用組成物
Friedberg The US clinical experience with bendamustine
Richardson et al. Prophylaxis and treatment of invasive fungal infections in neutropenic cancer and hematopoietic cell transplant patients
HK40038228A (en) Combination therapy
JP2023537474A5 (https=)
Alberts 7. Single agent chemotherapy in the management of